| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |